Who Buys Ritonavir from India — 525 Importers Behind a $340.6M Market
India's ritonavir import market is served by 525 active buyers who collectively imported $340.6M across 1,555 shipments. CENTRAL PHARMACEUTICAL CPC1. JSC (VIETNAM) leads with a 3.2% market share, followed by CENTRAL PHARMACEUTICAL CPC1.JSC and EXPEDITORS INTERNATIONAL NV. The top 5 buyers together control 14.1% of total import value, reflecting a moderately competitive buyer landscape.
Ritonavir buyer data — 525 importers · $340.6M market · 1,555 shipmentsTransData Nexus · Indian Customs Data
Top Ritonavir Importers — Ranked by Import Value
CENTRAL PHARMACEUTICAL CPC1. JSC (VIETNAM) is the leading ritonavir importer from India, holding a 3.2% share of the $340.6M market across 1,555 shipments from 525 buyers. The top 5 buyers — CENTRAL PHARMACEUTICAL CPC1. JSC (VIETNAM), CENTRAL PHARMACEUTICAL CPC1.JSC (VIETNAM), EXPEDITORS INTERNATIONAL NV (BELGIUM), PFIZER SER CO BV (BELGIUM), M S TO THE ORDER OF ESSERS LSP I (BELGIUM) — collectively control 14.1% of total import value.
Top Ritonavir Buyers & Importers
Ranked by import value · 525 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Ritonavir Buyers & Importers — Ranked by Import Value. 525 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Ritonavir — and from which countries?
Flow of Ritonavir exports from India: each country's share and the named importers behind the numbers
Ritonavir — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 74.1% of global Ritonavir imports — led by Belgium (51.5%) with a total trade value of $340.6M across 1,555 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Belgium
Belgium emerges as the first largest importing country, achieving a total trade value of $175.4M through 28 shipments. This represents a market share of 51.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• EXPEDITORS INTERNATIONAL NV - $10.0M (5.7% of country's total business)
• PFIZER SER CO BV - $8.5M (4.9% of country's total business)
• M S TO THE ORDER OF ESSERS LSP I - $8.5M (4.9% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $6.3M, indicating premium pricing strategy compared to the market average of $219.0K.
Belgium is a key market for Ritonavir imports, representing 51.5% of total trade value.
Primary Market
Secondary Market
2Indonesia
Indonesia emerges as the second largest importing country, achieving a total trade value of $26.6M through . This represents a market share of of the total market activity, demonstrating their significant presence in the industry.
The 525 buyers of Ritonavir from India can be categorized into several segments:
Distributors: Entities like Expeditors International NV (Belgium, $9.99M) and M S To The Order Of Essers LSP I (Belgium, $8.54M) function as intermediaries, purchasing Ritonavir in bulk and supplying it to various healthcare providers. Their buying behavior is characterized by large, consistent orders to maintain a steady supply chain.
Government Procurement Agencies: Organizations such as DIGECITSS - Ministerio de Salud Pública (Dominican Republic, $3.87M), National Medical Stores (Uganda, $3.04M), Ministry of Health and Child Care (Zimbabwe, $2.91M), and Embassy of the United States of America (Tanzania, $2.87M) procure Ritonavir through national tenders to supply public health facilities. Their purchasing patterns are typically large-scale and periodic, aligning with budget cycles and public health initiatives.
Hospital Groups: Entities like Central Pharmaceutical CPC1. JSC (Vietnam, $10.93M) and Central Pharmaceutical CPC1.JSC (Vietnam, $10.06M) are likely associated with hospital networks, purchasing Ritonavir to meet the therapeutic needs of their patients. Their orders are substantial and regular, reflecting ongoing patient treatment requirements.
The demand for Ritonavir in importing countries is primarily driven by the prevalence of HIV/AIDS, as Ritonavir is a key component in antiretroviral therapy. According to the World Health Organization (WHO), as of 2025, approximately 38 million people worldwide were living with HIV, with significant concentrations in sub-Saharan Africa and parts of Asia. Government healthcare programs, including national HIV treatment initiatives and universal health coverage expansions, have prioritized the procurement of essential medicines like Ritonavir. The inclusion of Ritonavir in the WHO Essential Medicines List facilitates its procurement through international and national tender-based purchasing mechanisms, ensuring broader access and affordability. The presence of 525 buyers across 155 countries underscores the global reliance on Ritonavir to manage HIV/AIDS, highlighting substantial market opportunities for suppliers.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Common Questions — Ritonavir Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest ritonavir buyer importing from India?
Based on import volume and value, CENTRAL PHARMACEUTICAL CPC1. JSC (VIETNAM) leads with $10.9M in imports and a 3.2% market share — the highest of any single ritonavir importer. CENTRAL PHARMACEUTICAL CPC1.JSC (VIETNAM) and EXPEDITORS INTERNATIONAL NV (BELGIUM) are the next largest buyers.
QHow many companies buy ritonavir from India?
There are 525 active ritonavir buyers importing from India, with a combined market of $340.6M across 1,555 shipments to 155 countries. The top 5 buyers hold 14.1% of total import value, while the remaining 520 buyers handle the other 85.9%.
QWhich countries import the most ritonavir from India?
The top importing countries for ritonavir from India are Belgium (51.5%), Indonesia (7.8%), Vietnam (6.3%), Rwanda (4.9%), South Africa (3.7%). These markets represent the largest demand centres for Indian pharmaceutical exports of ritonavir, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
The 525 buyers of Ritonavir from India can be categorized into several segments:
Distributors: Entities like Expeditors International NV (Belgium, $9.99M) and M S To The Order Of Essers LSP I (Belgium, $8.54M) function as intermediaries, purchasing Ritonavir in bulk and supplying it to various healthcare providers. Their buying behavior is characterized by large, consistent orders to maintain a steady supply chain.
Government Procurement Agencies: Organizations such as DIGECITSS - Ministerio de Salud Pública (Dominican Republic, $3.87M), National Medical Stores (Uganda, $3.04M), Ministry of Health and Child Care (Zimbabwe, $2.91M), and Embassy of the United States of America (Tanzania, $2.87M) procure Ritonavir through national tenders to supply public health facilities. Their purchasing patterns are typically large-scale and periodic, aligning with budget cycles and public health initiatives.
Hospital Groups: Entities like Central Pharmaceutical CPC1. JSC (Vietnam, $10.93M) and Central Pharmaceutical CPC1.JSC (Vietnam, $10.06M) are likely associated with hospital networks, purchasing Ritonavir to meet the therapeutic needs of their patients. Their orders are substantial and regular, reflecting ongoing patient treatment requirements.
The demand for Ritonavir in importing countries is primarily driven by the prevalence of HIV/AIDS, as Ritonavir is a key component in antiretroviral therapy. According to the World Health Organization (WHO), as of 2025, approximately 38 million people worldwide were living with HIV, with significant concentrations in sub-Saharan Africa and parts of Asia. Government healthcare programs, including national HIV treatment initiatives and universal health coverage expansions, have prioritized the procurement of essential medicines like Ritonavir. The inclusion of Ritonavir in the WHO Essential Medicines List facilitates its procurement through international and national tender-based purchasing mechanisms, ensuring broader access and affordability. The presence of 525 buyers across 155 countries underscores the global reliance on Ritonavir to manage HIV/AIDS, highlighting substantial market opportunities for suppliers.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
0 shipments
7.8%
Key Insight: Indonesia demonstrates strong market positioning with an average shipment value of $26.6M, indicating premium pricing strategy compared to the market average of $219.0K.
Indonesia is a key market for Ritonavir imports, representing 7.8% of total trade value.
Primary Market
Secondary Market
3Vietnam
Vietnam emerges as the third largest importing country, achieving a total trade value of $21.3M through 4 shipments. This represents a market share of 6.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Vietnam has a diverse importer base, with their top importers including:
• CENTRAL PHARMACEUTICAL CPC1. JSC - $10.9M (51.3% of country's total business)
• CENTRAL PHARMACEUTICAL CPC1.JSC - $10.1M (47.2% of country's total business)
Key Insight: Vietnam demonstrates strong market positioning with an average shipment value of $5.3M, indicating premium pricing strategy compared to the market average of $219.0K.
Vietnam is a key market for Ritonavir imports, representing 6.3% of total trade value.
Primary Market
Secondary Market
4Rwanda
Rwanda emerges as the fourth largest importing country, achieving a total trade value of $16.5M through 0 shipments. This represents a market share of 4.9% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Rwanda demonstrates strong market positioning with an average shipment value of $16.5M, indicating premium pricing strategy compared to the market average of $219.0K.
Rwanda is a key market for Ritonavir imports, representing 4.9% of total trade value.
Primary Market
Secondary Market
5South Africa
South Africa emerges as the fifth largest importing country, achieving a total trade value of $12.7M through 14 shipments. This represents a market share of 3.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: South Africa has a diverse importer base, with their top importers including:
• XXATRXX HEXXTHCXXE (XXY) XXD XXMPTXX PAXX - $2.4M (19.1% of country's total business)
• VIATRIS HEALTHCARE PTY LIMITED KEMPTON PARK - $2.4M (19.1% of country's total business)
Key Insight: South Africa demonstrates strong market positioning with an average shipment value of $904.1K, indicating premium pricing strategy compared to the market average of $219.0K.
South Africa is a key market for Ritonavir imports, representing 3.7% of total trade value.
Primary Market
Secondary Market
Retail Chains: Companies such as Sai Pharma Co Ltd (Thailand, $4.79M) operate retail pharmacies, acquiring Ritonavir to stock their outlets. Their purchasing behavior involves moderate-sized, frequent orders to ensure product availability for consumers.
Contract Manufacturers: Firms like Pfizer Ser Co BV (Belgium, $8.55M) may engage in contract manufacturing, sourcing Ritonavir as an active pharmaceutical ingredient for formulation into finished products. Their procurement is characterized by large, scheduled orders aligned with production cycles.
The repeat buyer rate of 47.2% indicates a significant level of ongoing demand, suggesting that nearly half of the buyers have established consistent procurement relationships, likely due to the critical role of Ritonavir in HIV treatment regimens.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Involves dossier submission, local clinical trials, and facility inspections.
Estimated Timeline: Approximately 12-18 months.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are subject to a 5% import duty.
Vietnam:
Regulatory Authority: Drug Administration of Vietnam (DAV).
Import Registration Process: Requires submission of a registration dossier, including product samples and manufacturing site information.
Estimated Timeline: Approximately 12 months.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are subject to a 0% import duty.
Rwanda:
Regulatory Authority: Rwanda Food and Drugs Authority (Rwanda FDA).
Import Registration Process: Involves submission of a registration application, product samples, and GMP certificates.
Estimated Timeline: Approximately 6-12 months.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are exempt from import duties.
South Africa:
Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).
Import Registration Process: Requires submission of a comprehensive dossier, including clinical data and GMP compliance.
Estimated Timeline: Approximately 24 months.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are subject to a 0% import duty.
TransData Nexus Research · Government and regulatory sourcesMar 2026
QWhat is the average import order value for ritonavir from India?
The average import transaction value for ritonavir from India is $219.0K, with an average unit price of $20.57 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Retail Chains: Companies such as Sai Pharma Co Ltd (Thailand, $4.79M) operate retail pharmacies, acquiring Ritonavir to stock their outlets. Their purchasing behavior involves moderate-sized, frequent orders to ensure product availability for consumers.
Contract Manufacturers: Firms like Pfizer Ser Co BV (Belgium, $8.55M) may engage in contract manufacturing, sourcing Ritonavir as an active pharmaceutical ingredient for formulation into finished products. Their procurement is characterized by large, scheduled orders aligned with production cycles.
The repeat buyer rate of 47.2% indicates a significant level of ongoing demand, suggesting that nearly half of the buyers have established consistent procurement relationships, likely due to the critical role of Ritonavir in HIV treatment regimens.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Involves dossier submission, local clinical trials, and facility inspections.
Estimated Timeline: Approximately 12-18 months.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are subject to a 5% import duty.
Vietnam:
Regulatory Authority: Drug Administration of Vietnam (DAV).
Import Registration Process: Requires submission of a registration dossier, including product samples and manufacturing site information.
Estimated Timeline: Approximately 12 months.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are subject to a 0% import duty.
Rwanda:
Regulatory Authority: Rwanda Food and Drugs Authority (Rwanda FDA).
Import Registration Process: Involves submission of a registration application, product samples, and GMP certificates.
Estimated Timeline: Approximately 6-12 months.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are exempt from import duties.
South Africa:
Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).
Import Registration Process: Requires submission of a comprehensive dossier, including clinical data and GMP compliance.
Estimated Timeline: Approximately 24 months.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are subject to a 0% import duty.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 525 global importers of Ritonavir identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 1,555 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 155 destination countries with market share per buyer calculated from capped values.
